A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer—Reply to letter to the editor by Petelin et al.

Li, Y., & Devlin, J. J. (2018, July 1). A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer—Reply to letter to the editor by Petelin et al. Value in Health. Elsevier Ltd. https://doi.org/10.1016/j.jval.2018.02.010